Envoy Medical Secures $10M In Financing To Advance Clinical Trial Of Acclaim Hearing Device

White Bear Lake, Minnesota--(Newsfile Corp. - March 12, 2025) - Envoy Medical®, Inc. (NASDAQ:COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced securing $10 Million in financing from its largest existing shareholder, billionaire entrepreneur Glen Taylor. The financing provides the Company with access to additional capital during what it expects to be a transformative year with several important milestones. The funds will be used to maintain the Company's velocity through its fully implanted Acclaim® cochlear implant pivotal clinical trial and support other operations.

"We are very happy with the enrollment progress in the first stage of our pivotal clinical trial," said Envoy Medical CEO Brent Lucas, "Investigational sites are reporting a tremendous amount of interest in our fully implanted cochlear implant. We believe that interest will only grow as awareness is increased and further progress is made. We are bullish on the reported desire of many cochlear implant candidates to have a device that is designed to be completely internal."